Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry

Journal of Neuroscience

Volumn 23, Issue 15, 2003, Pages 6351-6356

  Lewis, Simon J G ^a,b,e   Dove, Anja ^d   Robbins, Trevor W ^c   Barker, Roger A ^a,b   Owen, Adrian M ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UK   (United Kingdom)

^d MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Basal ganglia; Frontal lobes; Functional MRI; Heterogeneity; Parkinson's disease; Working memory

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HUMAN; MALE; MOTOR DYSFUNCTION; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; TASK PERFORMANCE; WORKING MEMORY;

ADULT; AGED; BRAIN MAPPING; COGNITION DISORDERS; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PHOTIC STIMULATION; REFERENCE VALUES; VERBAL BEHAVIOR;

EID: 0037705985     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aarsland D, Tandberg E, Larsen JP, Cummings JL (1996) Frequency of dementia in Parkinson disease. Arch Neurol 53:538-542.
2. Agid Y, Javoy-Agid E, Ruberg M (1987) Biochemistry of neurotransmitters in Parkinson's disease. In: Movement disorders (Marsden CD, Fahn S, eds), pp 166-230. London: Butterworth.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
4. Benton AL (1983) Differential behavioural effects of frontal lobe disease. Neuropsychologia 6:53-60.
5. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455.
6. Brett M, Leff AP, Rorden C, Ashburner J (2001) Spatial normalization of brain images with focal lesions using cost function masking. NeuroImage 14:486-500.
7. 18F-dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 166:141-151.
8. Brown RG, Marsden CD (1984) How common is dementia in Parkinson's disease? Lancet 2:1262-1265.
9. Bruck A, Portin R, Lindell A, Laihinen A, Bergman J, Haaparanta M, Solin O, Rinne JO (2001) Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 311:81-84.
10. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52:709-717.
11. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002) Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125:584-594.
12. Cusack R, Papadakis N (2002) New robust 3-d phase unwrapping algorithms: application to magnetic field mapping and undistorting echoplanar images. NeuroImage 16:754-764.
13. Dagher A, Owen AM, Boecker H, Brooks DJ (2001) The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 124:1020-1032.
14. D'Esposito M, Postle BR, Ballard D, Lease J (1999) Maintenance versus manipulation of information held in working memory: an event-related fMRI study. Brain Cogn 41:66-86.
15. Divac I, Rosvold HE, Szwarcbart MK (1967) Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 63:184-190.
16. Fahn S, Elton R (1987) Unified Parkinson's Disease Rating Scale. In: Recent developments in Parkinson's disease (Fahn S, Marsden CD, Calne D, Goldstein M, eds), pp 153-163. Florham Park, NJ: Macmillan Health Care Information.
17. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
18. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RS (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 2:189-210.
19. Friston KJ, Fletcher P, Josephs O, Holmes A, Rugg MD, Turner R (1998) Event-related fMRI: characterizing differential responses. NeuroImage 7:30-40.
20. Gibb WR, Lees AJ (1988a) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752.
21. Gibb WR, Lees AJ (1988b) A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 38:1402-1406.
22. Gibb WR, Luthert PJ, Janota I, Lantos PL (1989) Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 52:185-192.
23. Goldman-Rakic PS (1998) The cortical dopamine system: role in memory and cognition. Adv Pharmacol 42:707-711.
24. Goodglass H (1972) Assessment of aphasia and related disorders. Philadelphia: Lea and Febiger.
25. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442.
26. Holmes AP, Josephs O, Buechel C, Friston KJ (1997) Statistical modelling of low frequency confounds in fMRI. NeuroImage 5:S480.
27. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I (1990) Variable expression of Parkinson's disease:a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529-1534.
28. Jellinger KA (2001) The pathology of Parkinson's disease. Adv Neurol 86:55-72.
29. Jezzard P, Balaban RS (1995) Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med 34:65-73.
30. Karlsen KH, Larsen JP, Tandberg E, Maland JG (1998) Quality of life measurements in patients with Parkinson's disease: a community-based study. Eur J Neurol 5:443-450.
31. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM (1992) L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl) 107:394-404.
32. Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106:257-270.
33. Lewis SJ, Cools R, Robbins TW, Dove A, Barker RA, Owen AM (2003) Using executive heterogeneity to explore the nature of working memory deficits in Parkinson's disease. Neuropsychologia 41:645-654.
34. Marie RM, Barre L, Dupuy B, Viader F, Defer G, Baron JC (1999) Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260:77-80.
35. Mattay VS, Berman KF, Ostrem JL, Esposito G, Van Horn JD, Bigelow LB, Weinberger DR (1996) Dextroamphetamine enhances "neural network-specific" physiological signals: a positron-emission tomography rCBF study. J Neurosci 16:4816-4822.
36. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, Hyde TM, Weinberger DR (2002) Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51:156-164.
37. 18F]dopa metabolism in the striatum in Parkinson's disease. Brain 119:2097-2103.
38. Owen AM (2000) The role of the lateral frontal cortex in mnemonic processing: the contribution of functional neuroimaging. Exp Brain Res 133:33-43.
39. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW (1992) Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115:1727-1751.
40. Owen AM, Beksinska M, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Sahakian BJ, Robbins TW (1993) Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 31:627-644.
41. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC (1998a) Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 121:949-965.
42. Owen AM, Stern CE, Look RB, Tracey I, Rosen BR, Petrides M (1998b) Functional organization of spatial and nonspatial working memory processing within the human lateral frontal cortex. Proc Natl Acad Sci USA 95:7721-7726.
43. Petrides M (1994) Frontal lobes and working memory: evidence from investigations of the effects of cortical lesions in non-human primates. In: Handbook of neuropsychology (Boller F, Grafman J, eds), pp 59-82. Amsterdam: Elsevier.
44. Rinne JO, Rummukainen J, Paljarvi L, Rinne UK (1989) Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26:47-50.
45. 18F]fluorodopa positron emission tomographic study. Arch Neurol 57:470-475.
46. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275:321-328.
47. Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69:308-312.
48. Taylor AE, Saint-Cyr JA, Lang AE (1986) Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 109:845-883.
49. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996) A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:58-73.
50. Zetusky WJ, Jankovic J, Pirozzolo FJ (1985) The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 35:522-526.